Literature DB >> 32761369

Increased extracellular water measured by bioimpedance analysis and increased serum levels of atrial natriuretic peptide in polymyalgia rheumatica patients : Signs of volume overload.

F Günther1, B Ehrenstein2, W Hartung2, D Boschiero3, M Fleck2,4, R H Straub4.   

Abstract

BACKGROUND: Water retention is a typical feature of acute inflammatory episodes, chiefly implemented by the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. This is an important compensatory mechanism counteracting expected water loss, e.g., due to sweating. Both the SNS and HPA axis are activated in polymyalgia rheumatica (PMR). As retention mechanisms may similarly apply in this disease, we hypothesized increased water retention in PMR.
METHODS: Using bioimpedance analysis body composition was investigated in 64 healthy controls and 32 treatment-naive PMR patients. All PMR patients satisfied the 2012 EULAR/ACR classification criteria for PMR. 32 PMR patients were tested before and after 7 days of glucocorticoid-based therapy. Serum levels of pro-atrial natriuretic peptide (proANP) were investigated in all PMR patients and 15 healthy controls.
RESULTS: Extracellular water (ECW) was markedly higher in PMR patients than in controls (mean ± SD: 49.1 ± 6.0% versus 36.3 ± 2.5% of total body water, p < 0.001). Patients with PMR demonstrated significantly higher serum levels of proANP compared to controls. Even before glucocorticoid treatment was initiated, systolic and diastolic blood pressure were higher in PMR patients compared to controls. Extracellular water levels did not change in PMR patients upon 7 days of intensified treatment.
CONCLUSION: This study demonstrated increased extracellular water and elevated serum levels of proANP as signs of fluid overload in patients with PMR. Volume changes are imprinted as long-lasting mechanisms as water distribution is not affected by short-term anti-inflammatory therapy.

Entities:  

Keywords:  Hypertension; Hypothalamic-pituitary-adrenal axis; Inflammation; Sympathetic nervous system; proANP

Mesh:

Substances:

Year:  2021        PMID: 32761369     DOI: 10.1007/s00393-020-00845-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  43 in total

1.  Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis.

Authors:  J C Dekkers; R Geenen; G L Godaert; L J van Doornen; J W Bijlsma
Journal:  Arthritis Rheum       Date:  2000-02

2.  Neural control of the kidney: past, present, and future.

Authors:  Gerald F DiBona
Journal:  Hypertension       Date:  2002-12-16       Impact factor: 10.190

Review 3.  Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Authors:  Markus P Schlaich; Henry Krum; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

4.  Altered autonomic function in patients with arthritis or with chronic myofascial pain.

Authors:  Franklin Perry; Philip H Heller; Joe Kamiya; Jon D Levine
Journal:  Pain       Date:  1989-10       Impact factor: 6.961

Review 5.  Autonomic innervation and regulation of the immune system (1987-2007).

Authors:  Dwight M Nance; Virginia M Sanders
Journal:  Brain Behav Immun       Date:  2007-04-27       Impact factor: 7.217

6.  The autonomic nervous system and the immune system in juvenile rheumatoid arthritis.

Authors:  W Kuis; C de Jong-de Vos van Steenwijk; G Sinnema; A Kavelaars; B Prakken; P J Helders; C J Heijnen
Journal:  Brain Behav Immun       Date:  1996-12       Impact factor: 7.217

7.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.

Authors:  H Besedovsky; A del Rey; E Sorkin; C A Dinarello
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

8.  Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease.

Authors:  J C Dekkers; R Geenen; G L Godaert; J W Bijlsma; L J van Doornen
Journal:  Clin Exp Rheumatol       Date:  2004 Jan-Feb       Impact factor: 4.473

Review 9.  Decreased effective blood volume in edematous disorders: what does this mean?

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2007-06-13       Impact factor: 10.121

Review 10.  The sympathetic nervous response in inflammation.

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.